A support device for controlling breast thickness during stereotactic guided needle biopsy is provided. The support device includes a compressible support having an inner surface which extends adjacent to a substantial portion of a peripheral surface of a patient's breast when the breast and the support are disposed between the fixed and pressure plates of an apparatus for performing stereotactic guided needle biopsy. The compressible support restricts the inferior and lateral excursion of the breast as the plates are moved toward one another and the patient's breast and the compressible support are pressed between the plates. A method for controlling breast thickness during stereotactic guided needle biopsy is also provided.
|
1. An apparatus for performing stereotactic guided needle biopsy comprising a first plate and a second plate moveable with respect to one another and a support device, said support device comprising a compressible support having an inner surface extending adjacent to a substantial portion of a peripheral surface of a patient's breast when the breast and the compressible support are disposed between the first and second plates, said compressible support restricting inferior and lateral excursion of the breast as the first and second plates are moved toward one another and the patient's breast and the compressible support are pressed between the plates.
10. A method for controlling the thickness of a patient's breast during stereotactic guided needle biopsy, wherein the biopsy is performed with an apparatus having a fixed plate and a pressure plate movable with respect to one another, said method comprising the steps of:
positioning the patient's breast between the fixed plate and the pressure plate; positioning a compressible support between the fixed plate and the pressure plate and adjacent to a substantial portion of a peripheral surface of the patient's breast; pressing the patient's breast and the compressible support between the fixed plate and the pressure plate; and restricting the inferior and lateral excursion of the breast with the support to control the thickness of the patient's breast as the breast and the compressible support are pressed between the plates.
3. The support device of
4. The support device of
5. The support device of
7. The support device of
9. The support device of
12. The method of
13. The method of
14. The method of
16. The method of
17. The method of
18. The method of
19. The method of
20. The method of
|
|||||||||||||||||||||||||||
This invention concerns a device and a method for controlling the thickness of a patient's breast during the procedure of stereotactic guided needle breast biopsy. More particularly, this invention concerns a support device that is positioned adjacent to a patient's breast to limit the inferior and lateral excursion of the breast tissue as the breast is pressed during needle biopsy, which results in a significant increase in breast thickness.
Breast cancer is a leading killer of American women. However, very significant technical improvements in the sensitivity of mammography have been made over the past decade leading to much earlier detection of cancers in many patients. Early diagnosis and treatment results in dramatically improved cure rates. With the improved radiographic resolution which is available in current mammographic studies, radiologists are detecting a greater number of suspicious densities, microcalcifications and other tissue distortions that may represent an early cancer. Biopsy of these suspicious findings is very frequently recommended to determine whether or not the patient has a malignancy.
Customary surgical biopsy is an invasive procedure that requires hospitalization, general anesthesia, a surgical incision and the removal of one or more moderately large tissue specimens to be certain that the area in question is removed. Within the last 5 years, a method of tissue sampling has been developed, wherein a needle or canula is "fired" or injected into and through a suspicious lesion by a spring loaded biopsy device or "gun". In this method, known as stereotactic guided needle biopsy, the sampling needle is guided by preliminary stereotactic radiographs from which the exact location and depth of the lesion is calculated. This information is programmed into the biopsy device so that the sampling needle can be guided to and traverse the area to be sampled. Accuracy of needle placement is plus or minus 2 to 5 mm.
As mentioned above, the sampling needle must pass through the suspicious lesion. The minimum needle "throw" or excursion to obtain a satisfactory core from the lesion is about two centimeters. Since the minimum depth of a lesion to be biopsied in this procedure must be at least 1.0 to 1.5 cm, the actual needle movement is at least 3.5 cm through tissue. For this reason, the breast cannot be reduced in thickness to less than 3.5 cm in order to perform the biopsy by this method.
Newer needles for use in stereotactic guided needle biopsy have a trough about 2.0 cm in length near the tip. When the needle is inserted into a lesion, tissue from the lesion is drawn by suction into the trough and then excised by an inner coring sleeve. Needles of this design are rapidly gaining favor since they provide larger tissue samples which provides more accurate tissue analysis. However, these newer needles must also traverse the length of the tissue to be sampled, and the required amount of breast tissue traversed remains at no less than 3.5 cm.
Known apparatus for performing stereotactic guided needle biopsy is illustrated schematically in FIGS. 1 and 2. The apparatus, generally designated 10, includes a table 12 which can be elevated. The patient lies face down on a mattress 14 supported on the table. and the patient's breast 16 containing a lesion to be biopsied, such as the lesion 17, is suspended through a circular opening 18 approximately 20 cm. in diameter. A fixed, rigid plate 20 is position at one end of the opening 18 adjacent one side of the breast 16. A radiographic recording mechanism 22, either mammography film or an electronic digital recording screen, is located behind the fixed plate. On the other side of the breast, there is a movable, mechanically driven, translucent pressure plate 24 with a window opening 26. A biopsy needle 28, which is mounted in a spring loaded "gun" or injector 29, is aligned with the window opening 26, and a mammography xray tube 30 is positioned proximal to the compression plate.
In practice, the pressure plate is moved toward the fixed plate in the direction indicated by arrow A to moderately press or squeeze the breast between the plates 20 and 24. After initial radiographic images are taken to identify the lesion 17, the window 26 is positioned directly over the lesion. Two stereotactic views are then obtained by angling the xray tube 15 degrees to either side of a central line aimed at the lesion. The figures are programmed into the apparatus to determine the depth of the lesion within the breast.
Under sterile conditions and with local skin anesthesia, the biopsy needle 28 is then inserted into the breast just proximal to the target lesion 17. Accuracy of the needle placement is then assessed by means of another pair of stereo images. If the operator confirms that the area to be biopsied is directly opposite the needle tip, the spring loaded injector then "fires" or injects the needle at a high speed for a distance of about two centimeters so that the needle traverses the length of the lesion. A third set of stereotactic views is then taken. If the needle placement is satisfactory, sampling then proceeds.
As a woman ages, the supportive fibers of the breast lose their elasticity and the fibers elongate. These changes also occur in the skin envelope encompassing the breast. Although there are variations from patient to patient, some breasts become elongated, flaccid, and pendulous. When such a breast is initially pressed between the plates 20 and 24 during the first steps of a stereotactic needle biopsy, the total thickness of the breast can be as little as two centimeters. If the needle is injected in such a case, the 2 cm excursion of the needle will very likely cause the needle to pass through the back side of the breast, impinge on the fixed plate 20, break or penetrate the plate and impale the patient's breast. Accordingly, in cases where the patient's breast, after it is pressed between the plates 20 and 24, is too thin for stereotactic biopsy, i.e., the breast does not have a thickness greater than about 3.5 cm, stereotactic needle biopsy must be abandoned and the biopsy performed with a full surgical approach.
Human tissue is not compressible, i.e., there is no reduction in volume when human tissue and, more particularly, breast tissue is pressed or squeezed. Moreover, the skin has a very limited ability to stretch. Accordingly, when a breast is pressed or squeezed there is no change in the total volume of breast tissue. Instead, the tissue is displaced, flattened and altered in shape up to the limits permitted by the supportive fibers of the breast and the confines of the skin envelope.
When the patient's breast is pressed between the fixed plate 20 and the pressure plate 24 as shown in FIG. 2, the breast generally has the configuration of a half cylinder. The volume, V, of the tissue may be roughly computed by the following mathematical formula: ##EQU1## Where π is 3.14, r is the radius of the tissue cylinder, and h is the height or thickness of the cylinder.
If the radius r of the patient's breast is reduced, which is accomplished by reducing the area of the breast in contact with the pressure plate, then h or the thickness of the breast must increase in order to reflect the same volume of tissue. This reduction in the breast area in contact with the compression plate may be accomplished by restricting the displacement of the breast interiorly, medially and laterally as it is compressed.
The present invention provides a support device for controlling the thickness of a patient's breast during stereotactic guided needle biopsy. The device taught by the invention is used in conjunction with an apparatus for performing stereotactic guided needle biopsy of the type having a fixed plate and a pressure plate movable with respect to one another. The device comprises a compressible support having an inner surface which extends adjacent to a substantial portion of a peripheral surface of a patient's breast when the breast and the support are disposed between the fixed plate and the pressure plate of the above-described apparatus. The support controls the thickness of the patient's breast by restricting the inferior and lateral excursion of the breast as the breast and the compressible support are pressed between the plates.
This results in a redistribution of breast tissue characterized by a reduction in the radius of the breast and the surface area of the breast in contact with the plates and a corresponding increase in breast tissue thickness, in accordance with the formula set forth above. Thus, even in patients who would otherwise present a breast thickness of as little as 2 cm when the breast is pressed between the plates, use of the support device results in a redistribution of tissue which provides a breast thickness of at least about 3.5 cm. Accordingly, stereotactic guided needle biopsy can be performed on these patients with a safe, adequate layer of tissue beyond the tip of the injected needle.
In a preferred embodiment, the compressible support is sufficiently resilient so that when the plates are again moved apart to release the pressure on the patient's breast the support assumes it original shape. In a further preferred embodiment, the support device includes a layer of absorbent material disposed between the inner surface of the compressible support and the patient's breast. The layer of absorbent material absorbs and contains blood and other body fluids that may exude from the puncture site of the biopsy needle. In the most preferred embodiment of the invention, the compressible support comprises a flexible foam strip having an inner surface extending adjacent to a substantial portion of a peripheral surface of a patient's breast, and a layer of absorbent material affixed to the inner surface of the foam strip.
A method for controlling the thickness of a patient's breast during stereotactic needle biopsy is also provided.
FIG. 1 is a front view of a prior art apparatus for performing stereotactic guided needle biopsy with a patient's breast shown disposed between a fixed plate and a pressure plate of the apparatus.
FIG. 2 is a cross section taken along the line 2--2 of the apparatus of FIG. 1 with the patient's breast shown pressed between fixed plate and the pressure plate of the apparatus.
FIG. 3 is a side view of a support device embodying the present invention.
FIG. 4 is a bottom view of the support device shown in FIG. 3.
FIG. 5 is a top view of the support device shown in FIG. 3.
FIG. 6 is a front view of the apparatus shown in FIG. 1 with the patient's breast and the support device of FIG. 3 disposed between the fixed plate and the pressure plate of the apparatus.
FIG. 7 is a cross section taken along the line 7--7 of the apparatus shown in FIG. 1 with the patient's breast and the support device of FIG. 3 shown pressed between the fixed plate and the pressure plate of the apparatus.
FIGS. 3-5 illustrate a support device embodying the present invention. The support device, generally designated 50, comprises a compressible support or bolster 52 having a top surface 54, two side surfaces 56, 58 (one shown in FIG. 3), and a bottom surface 60. The bolster includes a main support portion 62 and an integrally formed tab portion 64 and is defined by a strip of compressible plastic foam. In the illustrated embodiment, the bolter 52 is formed from a strip of open cell urethane foam.
The overall length of the bolster 52 is variable but is satisfactory for all applications at 18 in. (45 cm), with the tab portion 64 having a length about 6 in. (15 cm). If a bolster of reduced length is required for a particular application, the length may be reduced by simply cutting the strip at any convenient point. The height is approximately 2 in. (5 cm), and the support portion 62 of the bolster has a width of approximately 3 in (7.5 cm). The tab portion 64 has a width of about 3/8 in. (4 mm). A plurality of transverse slits 66, 66 are incised across the top and bottom surfaces of the bolster to a depth of 1 or 2 cm to enhance the flexibility of the foam strip, although it should be understood that this is not necessary in all applications.
As illustrated best in FIG. 5, a layer 68 of absorbent material is supported on the top surface 54 of the bolster. As explained further below, the layer 68 of absorbent material contains and absorbs blood and other body fluids exuded from the needle puncture site, thus preventing these fluids from contaminating or even damaging the apparatus 10. The absorbent material comprising the layer 68 may be any sterile absorbent material commonly used in art, and the particular material employed in the illustrated embodiment is non woven methyl cellulose material. The layer 68 of absorbent material may be loosely placed on the top surface 54 of the bolster, or it may be affixed to this surface by, for example, applying adhesive to the bolster or the surface of the layer in contact with the bolster. Since the bolster 52 is intended to be a single use, disposable item, it is preferable to affix the layer 68 to the bolster with adhesive so that both items may be disposed of as a single package.
Referring now to FIGS. 6 and 7 the method of using the bolster 52 in a stereotactic guided needle biopsy procedure will be explained. The patient is placed prone or face down on the mattress 14 supported on the table 12, and the patient's breast 16 including the lesion 17 to be biopsied is introduced downwardly through the circular opening 18 formed in the table. As shown in FIG. 6, one end of the bolster 52 is secured to the table 10 by inserting the tab portion 64 between the mattress and the table. The bolster is then swung under the patient's breast and the pressure plate 24 is slowly advanced toward the fixed plate 20 in the direction indicated by arrow A. The foam comprising the bolster 52 compresses as the pressure plate 24 is moved toward the fixed plate 20. Accordingly, the bolster does not in any way hinder or prevent movement of the pressure plate, and once the bolster is pressed between the plates, it is securely but movably held in position between the plates by friction.
While slowly advancing the pressure plate toward the fixed plate, the operator presses upwardly and inwardly on the bolster in the direction indicated by arrows B, B. The bolster is thus manipulated into a cup-like receptacle that extends adjacent to a substantial peripheral portion of the patient's breast, as shown in FIG. 6. As the operator continues to move the pressure plate 24 toward the fixed plate 20 and the patient's breast and the bolster are pressed between the plates, the bolster presses inwardly and upwardly on the patient's breast to restrict the inferior and lateral excursion of the breast. This procedure is continued until the bolster and the patient's breast are in the configuration shown in FIG. 7.
Since, as noted above, breast tissue is not compressible, restriction of the inferior and lateral excursion of the breast by the bolster significantly reduces the radius of the breast and the surface area of the breast in contact with the plates as the bolster and the patient's breast are pressed between the plates. Accordingly, there is a corresponding increase in the thickness of the breast, as compared to the same breast pressed between the plates without the containing pressure applied by the bolster. The increase in breast thickness provided by the bolster is illustrated by comparing the thickness of the patient's breast as shown in FIG. 2 and the thickness of the breast as shown in FIG. 7.
The redistribution of breast tissue achieved with the use of the bolster provides sufficient breast thickness to permit injection of the needle 28 without the danger of the needle completely traversing the breast and impaling the patient's breast to the fixed plate 20. Thus, the present invention enables patients, who would otherwise have to undergo a surgical biopsy, to have breast lesions biopsied by the less invasive procedure of stereotactic needle biopsy. Moreover, since the compressible bolster provides additional support for the breast as the bolster and the patient's breast are pressed between the plates, the force necessary to secure the breast in position is reduced.
Accordingly, the patient experiences much less discomfort during the biopsy procedure, and the risk of tissue damage from prolonged and vigorous pressure which would otherwise have to be applied by the plates is significantly reduced. Still further, since the bolster assists in restricting the movement of the patient's breast between the plates, the risk of inadvertent and undetected repositioning of the breast during the needle biopsy procedure is reduced. This is critical, since such movement of the patient's breast could result in improper needle placement and incorrect tissue sampling.
As described above, a layer 68 of absorbent material is supported on the top surface 54 of the bolster. As shown best in FIG. 7, when the bolster 52 is placed against the patient's breast with the layer 68 of absorbent material immediately adjacent to the breast, the layer 68 extends vertically below the injection site 70 of the needle 28. Accordingly, any blood or other body fluids that exude from the injection site and seep between the pressure plate 24 and the patient's breast will flow by gravity into contact with the absorbent material. The material will contain and absorb these materials, thus preventing them from contaminating and potentially damaging the apparatus 10. Further, the layer of absorbent material reduces the exposure of operating personal to these body fluids.
While the support device of the present invention has been illustrated and described in connection with the preferred embodiment, it should be understood that the invention is not limited in this regard. For example, the bolster 52 is preferably a continuous strip of open cell polyurethane foam. However, other compressible materials, such as other open cell or partially open cell plastic foams, or synthetic or natural rubber are suitable for forming the bolseter. The important factors are that the material be sufficiently compressible so that it does not restrict movement of the plates while being sufficiently rigid to control the configuration of the patient's beast as the bolster and the patient's breast are pressed between the plates. In addition, the material must be sufficiently pliable to permit the bolster to conform to the changing configuration of the patient's breast as it is pressed between the plates, as well as conform to those portions of the biopsy apparatus which are in contact with the bolster.
Further, the support device of the present invention is not limited to the bolster 52 described and illustrated as the preferred embodiment. For example, instead of being provided as a continuous strip of foam, a plurality of discrete foam segments spaced between the plates and adjacent to the patients breast are also suitable. As the foam segments and the patient's breast are pressed between the plates, the foam segments are individually positioned adjacent a corresponding peripheral portion of the patient's breast until the breast is brought into the configuration illustrated in FIG. 7. Of course, each one of the foam segments can be individually provided with a layer of absorbent material supported on the surface of the segment disposed adjacent to the patient's breast.
It should also be understood that while the preferred embodiment of the invention is disclosed in connection with a stereotactic guided needle biopsy apparatus of the type illustrated in FIGS. 1, 2, 6 and 7, the invention is also suitable for use in apparatus having a different construction. For example, apparatus adaptable to standard mammography machines are known wherein the breast to be biopsied is positioned on a horizontal base, and a moveable pressure plate is disposed above and parallel to the base. To perform the biopsy, the pressure plate is lowered onto the breast. In a further modification, the base and the pressure plate are rotable from the horizontal position.
Accordingly, while preferred embodiments have been shown and described, various modifications and substitutions may be made without departing from the spirit and scope of the invention. It is, therefore, to be understood that the present invention has been described by way of example and not by limitation.
Russell, Donald G., Bober, Stewart E.
| Patent | Priority | Assignee | Title |
| 10070813, | Jan 20 2006 | Washington University | Photoacoustic and thermoacoustic tomography for breast imaging |
| 10105062, | Jan 09 2009 | Washington University | Miniaturized photoacoustic imaging apparatus including a rotatable reflector |
| 10359400, | Feb 11 2011 | California Institute of Technology | Multi-focus optical-resolution photoacoustic microscopy with ultrasonic array detection |
| 10433733, | Oct 25 2007 | Washington University | Single-cell label-free photoacoustic flowoxigraphy in vivo |
| 10695086, | Dec 09 2005 | SenoRx, Inc. | Guide block for biopsy or surgical devices |
| 11020006, | Oct 18 2012 | California Institute of Technology | Transcranial photoacoustic/thermoacoustic tomography brain imaging informed by adjunct image data |
| 11029287, | Feb 11 2011 | California Institute of Technology | Multi-focus optical-resolution photoacoustic microscopy with ultrasonic array detection |
| 11137375, | Nov 19 2013 | California Institute of Technology | Systems and methods of grueneisen-relaxation photoacoustic microscopy and photoacoustic wavefront shaping |
| 11369280, | Mar 01 2019 | California Institute of Technology | Velocity-matched ultrasonic tagging in photoacoustic flowgraphy |
| 11530979, | Aug 14 2018 | California Institute of Technology | Multifocal photoacoustic microscopy through an ergodic relay |
| 11592652, | Sep 04 2018 | California Institute of Technology | Enhanced-resolution infrared photoacoustic microscopy and spectroscopy |
| 11672426, | May 10 2017 | California Institute of Technology | Snapshot photoacoustic photography using an ergodic relay |
| 6254614, | Oct 18 1999 | PROCURE TREATMENT CENTERS, INC | Device and method for improved diagnosis and treatment of cancer |
| 6261299, | Nov 26 1999 | The Ohio State University; OHIO STATE UNIVERSITY, THE | Stereotactic apparatus and methods |
| 6533794, | Apr 19 2001 | The Ohio State University | Simplified stereotactic apparatus and methods |
| 6569176, | Oct 18 1999 | PROCURE TREATMENT CENTERS, INC | Device and method for improved diagnosis and treatment of cancer |
| 6872213, | Sep 13 1999 | The Ohio State University | Stereotactic apparatus and methods |
| 6904305, | Sep 29 1999 | Regents of the University of Minnesota | System for MRI-guided interventional mammary procedures |
| 6921406, | Apr 19 2001 | The Ohio State University | Stereotactic apparatus and methods |
| 7066922, | Oct 26 2001 | Massachusetts Institute of Technology | Transdermal transport device with suction |
| 7364568, | Oct 26 2001 | Massachusetts Institute of Technology | Microneedle transdermal transport device |
| 7429258, | Oct 26 2001 | Massachusetts Institute of Technology | Microneedle transport device |
| 7450688, | Jul 22 2005 | Wisconsin Alumni Research Foundation | Low skin dose patient positioning device for radiation treatment of prone breast |
| 7645263, | Oct 26 2001 | MASSACHUSETTS INSTUTUTE OF TECHNOLOGY | Impedance sensor |
| 7651475, | Oct 26 2001 | Massachusetts Institute of Technology | Microneedle transport device |
| 8246582, | Oct 26 2001 | Massachusetts Institute of Technology | Microneedle transdermal transport device |
| 8758265, | Dec 09 2005 | SenoRx, Inc. | Guide block for biopsy or surgical devices |
| 8997572, | Feb 11 2011 | California Institute of Technology | Multi-focus optical-resolution photoacoustic microscopy with ultrasonic array detection |
| 9055926, | Dec 09 2005 | Senorx, Inc | Guide block for biopsy or surgical devices |
| 9086365, | Apr 09 2010 | Washington University | Quantification of optical absorption coefficients using acoustic spectra in photoacoustic tomography |
| 9226666, | Oct 25 2007 | Washington University | Confocal photoacoustic microscopy with optical lateral resolution |
| 9351705, | Jan 09 2009 | Washington University | Miniaturized photoacoustic imaging apparatus including a rotatable reflector |
| 9439571, | Jan 20 2006 | Washington University | Photoacoustic and thermoacoustic tomography for breast imaging |
| 9655527, | Apr 09 2010 | Washington University | Quantification of optical absorption coefficients using acoustic spectra in photoacoustic tomography |
| 9700349, | Dec 09 2005 | SenoRx, Inc. | Guide block for biopsy or surgical devices |
| 9814486, | Dec 09 2005 | SenoRx, Inc. | Guide block for biopsy or surgical devices |
| D638124, | Nov 16 2009 | FUJIFILM Corporation | Biopsy needle support device |
| Patent | Priority | Assignee | Title |
| 4691333, | Dec 27 1985 | Breast compression and needle localization apparatus | |
| 5507049, | Aug 03 1994 | Lance supports |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Mar 31 1998 | Donald G., Russell | (assignment on the face of the patent) | / | |||
| Mar 31 1998 | Stewart E., Bober | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Apr 21 2003 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
| Feb 28 2007 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
| May 30 2011 | REM: Maintenance Fee Reminder Mailed. |
| Oct 26 2011 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
| Date | Maintenance Schedule |
| Oct 26 2002 | 4 years fee payment window open |
| Apr 26 2003 | 6 months grace period start (w surcharge) |
| Oct 26 2003 | patent expiry (for year 4) |
| Oct 26 2005 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Oct 26 2006 | 8 years fee payment window open |
| Apr 26 2007 | 6 months grace period start (w surcharge) |
| Oct 26 2007 | patent expiry (for year 8) |
| Oct 26 2009 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Oct 26 2010 | 12 years fee payment window open |
| Apr 26 2011 | 6 months grace period start (w surcharge) |
| Oct 26 2011 | patent expiry (for year 12) |
| Oct 26 2013 | 2 years to revive unintentionally abandoned end. (for year 12) |